Add Alzheimer's disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says. People with Type 2 diabetes taking semaglutide appeared to have a ...

Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for Alzheimer’s disease, a new study shows. People with type 2 diabetes who took ...

Share on Pinterest A new study suggests that young adults with diabetes may have a higher risk of developing Alzheimer’s disease. Courtney Hale/Getty Images A new study suggests that early-onset ...

Having diabetes was linked to changes in blood associated with Alzheimer's disease (AD) and brain damage in Latino adults, ...

Share on Pinterest Semaglutide, the active ingredient in Ozempic and Wegovy, may also help lower the risk of developing Alzheimer’s disease in people living with type 2 diabetes. damkaz/Getty Images ...

People with type 2 diabetes are at increased risk of Alzheimer's disease and other cognitive problems. A new study shows that the reason may be that people with type 2 diabetes have more difficulty ...

Diabetes is known to cause many medical issues, from heart disease to vision problems — and now a new study suggests it could also impact memory and other cognitive functions. After observing brain ...

Researchers from the University of California San Diego have found that diabetes is linked to changes in measurable biological signals in the blood that are associated with Alzheimer's disease and ...

Thanks to the fundraising, the Barnstable Brown Diabetes Research Center at the University of Kentucky is studying the ...

Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes, according to a study published Thursday in the journal ...